Robert Morlock

2.2k total citations
97 papers, 1.6k citations indexed

About

Robert Morlock is a scholar working on Nephrology, Rheumatology and Surgery. According to data from OpenAlex, Robert Morlock has authored 97 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Nephrology, 20 papers in Rheumatology and 19 papers in Surgery. Recurrent topics in Robert Morlock's work include Gout, Hyperuricemia, Uric Acid (28 papers), Urticaria and Related Conditions (14 papers) and Case Reports on Hematomas (10 papers). Robert Morlock is often cited by papers focused on Gout, Hyperuricemia, Uric Acid (28 papers), Urticaria and Related Conditions (14 papers) and Case Reports on Hematomas (10 papers). Robert Morlock collaborates with scholars based in United States, United Kingdom and Canada. Robert Morlock's co-authors include Douglas E. Feltner, Valerie Williams, Louis S. Matza, Karen G. Malley, Christopher Sexton, Albert I. Wertheimer, Michael A. Becker, Scott Baumgartner, Gail A. Jensen and Michael A. Morrisey and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Robert Morlock

93 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Robert Morlock United States 21 293 278 237 220 196 97 1.6k
Xuan Cai United States 18 245 0.8× 458 1.6× 118 0.5× 132 0.6× 71 0.4× 38 1.9k
Olivier Phan France 23 153 0.5× 524 1.9× 124 0.5× 99 0.5× 43 0.2× 71 1.8k
Chao Cao United States 19 152 0.5× 82 0.3× 363 1.5× 66 0.3× 255 1.3× 70 1.8k
Moshe Fridman United States 32 202 0.7× 131 0.5× 282 1.2× 98 0.4× 674 3.4× 132 3.8k
Silvia Maffei Italy 29 229 0.8× 69 0.2× 224 0.9× 48 0.2× 120 0.6× 89 2.7k
Timothy W. Smith United States 26 276 0.9× 395 1.4× 43 0.2× 135 0.6× 104 0.5× 60 2.5k
Alicia Gilsenan United States 17 117 0.4× 52 0.2× 253 1.1× 127 0.6× 264 1.3× 42 1.6k
Umesh Masharani United States 30 1.0k 3.5× 66 0.2× 113 0.5× 94 0.4× 280 1.4× 95 5.2k
Julie Hunt United States 23 146 0.5× 55 0.2× 137 0.6× 178 0.8× 461 2.4× 43 2.8k
Line Jee Hartmann Rasmussen Denmark 22 113 0.4× 57 0.2× 104 0.4× 153 0.7× 95 0.5× 67 1.7k

Countries citing papers authored by Robert Morlock

Since Specialization
Citations

This map shows the geographic impact of Robert Morlock's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert Morlock with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert Morlock more than expected).

Fields of papers citing papers by Robert Morlock

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert Morlock. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert Morlock. The network helps show where Robert Morlock may publish in the future.

Co-authorship network of co-authors of Robert Morlock

This figure shows the co-authorship network connecting the top 25 collaborators of Robert Morlock. A scholar is included among the top collaborators of Robert Morlock based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert Morlock. Robert Morlock is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mayer, Erica L., Mary Lou Smith, Annie Guérin, et al.. (2025). Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2− early breast cancer: a discrete choice survey study. Breast Cancer Research and Treatment. 211(1). 121–130. 1 indexed citations
2.
Singh, Jasvinder A., et al.. (2024). Gout Flare Burden in the United States: A Multiyear Cross‐Sectional Survey Study. ACR Open Rheumatology. 7(1). e11759–e11759. 2 indexed citations
3.
Morlock, Robert, Deepan Dalal, Victoria Divino, et al.. (2024). Characteristics and Management of Uncontrolled Gout Prior to Pegloticase Therapy: A 2-year Claims Analysis. Rheumatology and Therapy. 12(1). 37–51.
4.
Kesselheim, Aaron S., et al.. (2024). National Survey of Factors Associated with Physician Antibiotic Prescribing Preferences. Journal of General Internal Medicine. 40(4). 838–846.
5.
Ye, Xiaolan, et al.. (2023). S623 Treatment Satisfaction and Quality of Life in Patients with Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation. The American Journal of Gastroenterology. 118(10S). S457–S458. 1 indexed citations
6.
Morlock, Robert, et al.. (2023). Think Before You Ink: Perception, Prevalence, and Correlates of Tattooing and Tattoo Regret in US Adults. Cureus. 15(11). e48167–e48167. 3 indexed citations
7.
Cella, David, Arijit Ganguli, James Turnbull, Jeffrey M. Rohay, & Robert Morlock. (2022). US Population Reference Values for Health-Related Quality of Life Questionnaires Based on Demographics of Patients with Prostate Cancer. Advances in Therapy. 39(8). 3696–3710. 1 indexed citations
8.
Morlock, Robert, et al.. (2021). COVID-19 prevalence and predictors in United States adults during peak stay-at-home orders. PLoS ONE. 16(1). e0245586–e0245586. 18 indexed citations
9.
Jaffe, Dena H., Alyssa Klein, Arriel Benis, et al.. (2019). Incident gout and chronic Kidney Disease: healthcare utilization and survival. BMC Rheumatology. 3(1). 11–11. 18 indexed citations
10.
Stack, Austin G., Betina T. Blak, Alyssa Klein, et al.. (2019). Gout and the risk of advanced chronic kidney disease in the UK health system: a national cohort study. BMJ Open. 9(8). e031550–e031550. 30 indexed citations
11.
Stevens, Vanessa, David D. Stenehjem, Olga V. Patterson, et al.. (2018). Characterization and survival of patients with metastatic basal cell carcinoma in the Department of Veterans Affairs: a retrospective electronic health record review. Archives of Dermatological Research. 310(6). 505–513. 3 indexed citations
12.
Wahlqvist, P, et al.. (2018). Cost-effectiveness of Simple Insulin Infusion Devices Compared to Multiple Daily Injections in Uncontrolled Type 2 Diabetics in the United States Based on a Simulation Model. Journal of health economics and outcomes research. 6(1). 84–95. 9 indexed citations
13.
14.
Morlock, Robert, Pierre Chevalier, Laura Horne, et al.. (2016). Disease Control, Health Resource Use, Healthcare Costs, and Predictors in Gout Patients in the United States, the United Kingdom, Germany, and France: A Retrospective Analysis. Rheumatology and Therapy. 3(1). 53–75. 5 indexed citations
15.
16.
Byfield, Stacey DaCosta, et al.. (2013). Corroboration of claims algorithm for second-line costs of metastatic colorectal cancer treatment with targeted agents. Journal of Medical Economics. 16(8). 1071–1081. 6 indexed citations
17.
18.
Lau, Denys T., Robert Morlock, & Cheryl Hill. (2006). Psychometric evaluation of the medical outcomes study-sleep scale in persons with overactive bladder. Clinical Therapeutics. 28(12). 2119–2132. 15 indexed citations
19.
Lafata, Jennifer Elston, Christine Cole Johnson, Tamir Ben‐Menachem, & Robert Morlock. (2001). Sociodemographic Differences in the Receipt of Colorectal Cancer Surveillance Care Following Treatment With Curative Intent. Medical Care. 39(4). 361–372. 67 indexed citations
20.
Morlock, Robert. (2000). Cost-effectiveness of single-dose methotrexate compared with laparoscopic treatment of ectopic pregnancy. Obstetrics and Gynecology. 95(3). 407–412. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuan Cai Breakdown of academic impact, for papers by Olivier Phan Breakdown of academic impact, for papers by Chao Cao Breakdown of academic impact, for papers by Moshe Fridman Breakdown of academic impact, for papers by Silvia Maffei Breakdown of academic impact, for papers by Timothy W. Smith Breakdown of academic impact, for papers by Alicia Gilsenan Breakdown of academic impact, for papers by Umesh Masharani Breakdown of academic impact, for papers by Julie Hunt Breakdown of academic impact, for papers by Line Jee Hartmann Rasmussen
Rankless by CCL
2026